Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

After the White House used a Sabrina Carpenter song without her permission, the pop star is keeping her response short and sweet. The "Espresso" singer, 26, took to X to slam the White House for using ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

What is it with lawyers and AI? We don’t know, but it feels like an inordinate number of them keep screwing up with AI tools, apparently never learning from their colleagues who get publicly crucified ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Some senior officials who have taken the test have been asked whether they said anything negative about the F.B.I. director, Kash Patel. By Adam Goldman Reporting from Washington Typically, the F.B.I.